Agency Information Collection Activities: Submission for OMB Review; Comment Request, 35759-35761 [2014-14713]
Download as PDF
<![CDATA[
Federal Register / Vol. 79, No. 121 / Tuesday, June 24, 2014 / Notices
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Institute of
Diabetes and Digestive and Kidney Diseases
Special Emphasis Panel, Ancillary Study in
Bariatric Surgery.
Date: July 24, 2014.
Time: 3:00 p.m. to 5:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health, Two
Democracy Plaza, 6707 Democracy
Boulevard, Bethesda, MD 20892, (Telephone
Conference Call).
Contact Person: Maria E. Davila-Bloom,
Ph.D., Scientific Review Officer, Review
Branch, DEA, NIDDK, National Institutes of
Health, Room 758, 6707 Democracy
Boulevard, Bethesda, MD 20892–5452, (301)
594–7637, davilabloomm@extra.niddk.nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.847, Diabetes,
Endocrinology and Metabolic Research;
93.848, Digestive Diseases and Nutrition
Research; 93.849, Kidney Diseases, Urology
and Hematology Research, National Institutes
of Health, HHS)
Dated: June 18, 2014.
David Clary,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2014–14649 Filed 6–23–14; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
mstockstill on DSK4VPTVN1PROD with NOTICES
National Institute of Biomedical
Imaging and Bioengineering; Notice of
Closed Meeting
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. App.), notice is
hereby given of the following meeting.
The meeting will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
VerDate Mar<15>2010
23:01 Jun 23, 2014
Jkt 232001
Name of Committee: National Institute of
Biomedical Imaging and Bioengineering
Special Emphasis Panel NIBIB R25 Review.
Date: November 20, 2014.
Time: 12:00 p.m. to 4:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health, Two
Democracy Plaza, 6707 Democracy
Boulevard, Bethesda, MD 20892, (Virtual
Meeting).
Contact Person: Ruth Grossman, DDS,
Scientific Review Officer, National Institute
of Biomedical Imaging and Bioengineering,
6707 Democracy Boulevard, Room 960,
Bethesda, MD 20892, 301–496–8775,
grossmanrs@mail.nih.gov.
Dated: June 18, 2014.
David Clary,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2014–14648 Filed 6–23–14; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
Center for Scientific Review; Notice of
Closed Meetings
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. App.), notice is
hereby given of the following meetings.
The meetings will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications ,the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: Center for Scientific
Review Special Emphasis Panel Member
conflict: Topics in Bacterial Pathogenesis.
Date: July 15–16, 2014.
Time: 8:00 a.m. to 6:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health, 6701
Rockledge Drive, Bethesda, MD 20892,
(Virtual Meeting).
Contact Person: Guangyong Ji, Ph.D.,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 3211,
MSC 7808, Bethesda, MD 20892, 301–435–
1146, jig@csr.nih.gov.
Name of Committee: Center for Scientific
Review Special Emphasis Panel Small
Business: Molecular Analysis Technology.
Date: July 23, 2014.
Time: 11:00 a.m. to 6:00 p.m.
Agenda: To review and evaluate grant
applications.
PO 00000
Frm 00039
Fmt 4703
Sfmt 4703
35759
Place: National Institutes of Health, 6701
Rockledge Drive, Bethesda, MD 20892,
(Telephone Conference Call).
Contact Person: Zhang-Zhi Hu, MD,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 6186,
MSC 7804, Bethesda, MD 20892, (301) 594–
2414, huzhuang@csr.nih.gov.
Name of Committee: Center for Scientific
Review Special Emphasis Panel PA13–313:
Academic Research Enhancement Award
(R15) Program: Endocrinology, Metabolism,
Nutrition and Reproduction.
Date: July 23, 2014.
Time: 1:00 p.m. to 6:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health, 6701
Rockledge Drive, Bethesda, MD 20892,
(Telephone Conference Call).
Contact Person: Reed A Graves, Ph.D.,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 6166,
MSC 7892, Bethesda, MD 20892, (301) 402–
6297, gravesr@csr.nih.gov.
Name of Committee: Center for Scientific
Review Special Emphasis Panel Program
Project: BTRC Center Review.
Date: July 23–25, 2014.
Time: 6:00 p.m. to 3:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: Bethesda Marriott Suites, 6711
Democracy Boulevard, Bethesda, MD 20817.
Contact Person: Craig Giroux, Ph.D.,
Scientific Review Officer, BST IRG, Center
for Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 5150,
Bethesda, MD 20892, 301–435–2204,
girouxcn@csr.nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.306, Comparative Medicine;
93.333, Clinical Research, 93.306, 93.333,
93.337, 93.393–93.396, 93.837–93.844,
93.846–93.878, 93.892, 93.893, National
Institutes of Health, HHS)
Dated: June 18, 2014.
David Clary,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2014–14645 Filed 6–23–14; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Substance Abuse and Mental Health
Services Administration
Agency Information Collection
Activities: Submission for OMB
Review; Comment Request
Periodically, the Substance Abuse and
Mental Health Services Administration
(SAMHSA) will publish a summary of
information collection requests under
OMB review, in compliance with the
Paperwork Reduction Act (44 U.S.C.
Chapter 35). To request a copy of these
E:\FR\FM\24JNN1.SGM
24JNN1
35760
Federal Register / Vol. 79, No. 121 / Tuesday, June 24, 2014 / Notices
documents, call the SAMHSA Reports
Clearance Officer on (240) 276–1243.
Project: 2015 National Survey on Drug
Use and Health (OMB No. 0930–0110)—
Revision
The National Survey on Drug Use and
Health (NSDUH) is a survey of the U.S.
civilian, non-institutionalized
population aged 12 years old or older.
The data are used to determine the
prevalence of use of tobacco products,
alcohol, illicit substances, and illicit use
of prescription drugs. The results are
used by SAMHSA, the Office of
National Drug Control Policy (ONDCP),
Federal government agencies, and other
organizations and researchers to
establish policy, direct program
activities, and better allocate resources.
In order to continue producing
current data, SAMHSA’s Center for
Behavioral Health Statistics and Quality
(CBHSQ) must periodically update
aspects of the NSDUH to reflect the
changing substance use and mental
health issues and to continue producing
current data. CBHSQ has such plans for
the 2015 NSDUH survey year to achieve
two goals: (1) Revise the questionnaire
to address changing policy and research
data needs, and (2) modify the survey
methodology to improve the quality of
estimates and the efficiency of data
collection and processing.
Planned revisions for the 2015
NSDUH to the questionnaire,
methodology and materials, including
an assessment of new computer
equipment, were initially tested in 2012
as part of the NSDUH Questionnaire
Field Test (QFT) (OMB No. 0930–0334),
then further refined and tested again in
2013 during the NSDUH Dress
Rehearsal (DR) (OMB No. 0930–0334).
As such, most of the changes described
herein were successfully tested as part
of the QFT and/or DR unless otherwise
specified.
The changes to the questionnaire
content for 2015 will include: (a)
Revisions to modules for smokeless
tobacco, hallucinogens, inhalants,
prescription drugs, special drugs,
consumption of alcohol, and health
care; (b) revisions to the educational
attainment response categories; (c) a
lower threshold of binge alcohol use for
females; (d) a new methamphetamine
module; (e) addition of two sexual
orientation questions to be asked of
adults; and (f) revisions to back-end
demographics questions. Also, to aid
respondent recall within the
questionnaire, prescription drug images
and a reference date calendar will
display on the computer screen rather
than being displayed in hard-copy,
paper form.
There are a few additional changes to
the questionnaire content for 2015 not
tested during the DR, which include: (a)
The term ‘‘Molly’’ will be added to
questions about Ecstasy in the
hallucinogens module; (b) routine
updates to logic and wording for
consistency and to maximize
respondent comprehension; and (c)
other minor changes to questions
throughout the instrument to clarify
intent.
Several changes are also planned to
the methodology for 2015 in an effort to
improve the efficiency of data collection
and processing; these were tested during
the QFT and DR. A new 7-inch touch
screen tablet will be used for screening
and interview respondent selection, in
addition to a new lightweight laptop
used to administer the questionnaire.
Also redesigned versions of the lead
letter (mailed to respondents prior to
being contacted by an interviewer) and
a question & answer brochure will be
provided to respondents. As necessary,
all materials provided to respondents
for 2015 will be updated to now
reference the U.S. Department of Health
and Human Services (instead of U.S.
Public Health Service) and any previous
mention of the Contractor, Research
Triangle Institute, will now appear as
RTI International. Due to changes to the
questionnaire content, the showcard
booklet, which allows respondents to
refer to information necessary for
accurate responses, will contain fewer
showcards.
Along with the new laptop, text to
speech (TTS) software is being
programmed and tested for
implementation within the
questionnaire for 2015. TTS uses a
computer-generated voice to read text
displayed on-screen, rather than relying
on the pre-recorded audio files from a
human voice used previously with the
audio computer-assisted selfinterviewing (ACASI) portions of the
interview. Though TTS was not tested
as part of the QFT or DR, during an
evaluation of the software, there were
no problems understanding any words
or phrases produced by the TTS voices
in English or Spanish, so it will be
implemented for the 2015 NSDUH
unless there is a significant problem
shown during testing. If TTS is not
implemented, the current method of
using pre-recorded audio files will be
continued for the 2015 NSDUH.
In addition, interviewers will now
have the option of showing a short
video via the multimedia capability of
the touch screen tablet. The video
(approx. 50 seconds in run time) will
provide a brief explanation of the study
and why participation is important.
Also contained within the tablet and
new for 2015 is a parental introductory
script, designed to be read to a parent
or guardian once a youth respondent is
selected to complete an interview. This
script will standardize the introductory
conversations with parent/guardians.
As with all NSDUH/NHSDA (prior to
2002, the NSDUH was referred to as the
National Household Survey on Drug
Abuse (NHSDA)) surveys conducted
since 1999, the sample size of the
survey for 2015 will be sufficient to
permit prevalence estimates for each of
the fifty States and the District of
Columbia. The sample design for 2015
will be the same as the design used for
2014 data collection. This design places
more sample in the 26 or older age
groups to more accurately estimate drug
use and related mental health measures
among the aging drug use population,
and allows for the possible adoption of
address-based sampling in the future.
The total annual burden estimate is
shown in Table 1.
TABLE 1—ANNUALIZED ESTIMATED BURDEN FOR 2015 NSDUH
Number of
respondents
mstockstill on DSK4VPTVN1PROD with NOTICES
Instrument
Responses
per
respondent
Total number
of responses
Hours per
response
Total burden
hours
Household Screening ...........................................................
Interview ...............................................................................
Screening Verification ..........................................................
Interview Verification ............................................................
125,176
67,507
3,755
10,126
1
1
1
1
125,176
67,507
3,755
10,126
0.083
1.000
0.067
0.067
10,390
67,507
252
678
Total ..............................................................................
125,176
........................
125,176
........................
78,827
VerDate Mar<15>2010
23:01 Jun 23, 2014
Jkt 232001
PO 00000
Frm 00040
Fmt 4703
Sfmt 4703
E:\FR\FM\24JNN1.SGM
24JNN1
35761
Federal Register / Vol. 79, No. 121 / Tuesday, June 24, 2014 / Notices
Written comments and
recommendations concerning the
proposed information collection should
be sent by July 24, 2014 to the SAMHSA
Desk Officer at the Office of Information
and Regulatory Affairs, Office of
Management and Budget (OMB). To
ensure timely receipt of comments, and
to avoid potential delays in OMB’s
receipt and processing of mail sent
through the U.S. Postal Service,
commenters are encouraged to submit
their comments to OMB via email to:
OIRA_Submission@omb.eop.gov.
Although commenters are encouraged to
send their comments via email,
commenters may also fax their
comments to: 202–395–7285.
Commenters may also mail them to:
Office of Management and Budget,
Office of Information and Regulatory
Affairs, New Executive Office Building,
Room 10102, Washington, DC 20503.
Summer King,
Statistician.
[FR Doc. 2014–14713 Filed 6–23–14; 8:45 am]
BILLING CODE 4162–20–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Substance Abuse and Mental Health
Services Administration
Agency Information Collection
Activities: Submission for OMB
Review; Comment Request
Periodically, the Substance Abuse and
Mental Health Services Administration
(SAMHSA) will publish a summary of
information collection requests under
OMB review, in compliance with the
Paperwork Reduction Act (44 U.S.C.
Chapter 35). To request a copy of these
documents, call the SAMHSA Reports
Clearance Officer on (240) 276–1243.
mstockstill on DSK4VPTVN1PROD with NOTICES
Project: Protection and Advocacy for
Individuals With Mental Illness
(PAIMI) Annual Program Performance
Report (OMB No. 0930–0169)—
Extension
The Protection and Advocacy for
Individuals with Mental Illness (PAIMI)
Act at 42 U.S.C. 10801 et seq.,
authorized funds to the same protection
and advocacy (P&A) systems created
under the Developmental Disabilities
Assistance and Bill of Rights Act of
1975, known as the DD Act (as amended
in 2000, 42 U.S.C. 15001 et seq.]. The
DD Act supports the Protection and
Advocacy for Developmental
Disabilities (PADD) Program
administered by the Administration on
Intellectual and Developmental
Disabilities (AIDD) within the
Administration on Community Living.
AIDD is the lead federal P&A agency.
The PAIMI Program supports the same
governor-designated P&A systems
established under the DD Act by
providing legal-based individual and
systemic advocacy services to
individuals with significant (severe)
mental illness (adults) and significant
(severe) emotional impairment
(children/youth) who are at risk for
abuse, neglect and other rights
violations while residing in a care or
treatment facility.
In 2000, the PAIMI Act amendments
created a 57th P&A system—the
American Indian Consortium (the
Navajo and Hopi Tribes in the Four
Corners region of the Southwest). The
Act, at 42 U.S.C. 10804(d), states that a
P&A system may use its allotment to
provide representation to individuals
with mental illness, as defined by
section 42 U.S.C. 10802 (4)(B)(iii)
residing in the community, including
their own home, only, if the total
allotment under this title for any fiscal
year is $30 million or more, and in such
cases an eligible P&A system must give
priority to representing PAIMI-eligible
individuals, as defined by 42 U.S.C.
10802(4)(A) and (B)(i).
The Children’s Health Act of 2000
(CHA) also referenced the state P&A
system authority to obtain information
on incidents of seclusion, restraint and
related deaths [see, CHA, Part H at 42
U.S.C. 290ii–1]. PAIMI Program formula
grants awarded by SAMHSA go directly
to each of the 57 governor-designated
P&A systems. These systems are located
in each of the 50 states, the District of
Columbia, the American Indian
Consortium, American Samoa, Guam,
the Commonwealth of the Northern
Mariana Islands, the Commonwealth of
Puerto Rico, and the U.S. Virgin Islands.
Number of
respondents
The PAIMI Act at 42 U.S.C. 10805(7)
requires that each P&A system prepare
and transmit to the Secretary HHS and
to the head of its State mental health
agency a report on January 1. This
report describes the activities,
accomplishments, and expenditures of
the system during the most recently
completed fiscal year, including a
section prepared by the advisory
council (the PAIMI Advisory Council or
PAC) that describes the activities of the
council and its independent assessment
of the operations of the system.
The Substance Abuse Mental Health
Services Administration (SAMHSA)
proposes no revisions to its annual
PAIMI Program Performance Report
(PPR), including the advisory council
section, at this time for the following
reasons: (1) AIDD is currently piloting a
PADD PPR. The results of the pilot will
not be available until October 2014 (FY
2015). (2) when the AIDD/ACL PPR is
final, SAMHSA will revise its PPR, as
appropriate, for consistency with the
annual reporting requirements under
the PAIMI Act and Rules [42 CFR Part
51]; (3) SAMHSA will develop a
mechanism to facilitate electronic
submission of the annual PAIMI PPR
and ACR as recommended in the
Evaluation of the Protection and
Advocacy for Individuals with Mental
Illness (PAIMI) Program, Phase III.
Evaluation Report al Report (SAMHSA
(2011). Evaluation of the Protection and
Advocacy for Individuals With Mental
Illness (PAIMI) Program, Phase III. Final
Report. HHS Pub. No. PEP12–
EVALPAIMI. Rockville, MD: CMHS,
SAMHSA). (4) GPRA requirements for
the PAIMI Program will be revised as
appropriate to ensure that SAMHSA
obtains information that closely
measures actual outcomes of programs
that it funds and (5) SAMHSA will
reduce wherever feasible the current
reporting burden by removing any
information that does not facilitate
evaluation of the programmatic and
fiscal effectiveness of a state P&A
system. The current report formats will
be effective for the FY 2014 PPR reports
due on January 1, 2015.
The annual burden estimate is as
follows:
Number of
responses per
respondent
Hours per
response
Total hour
burden
Program Performance Report .........................................................................
Advisory Council Report ..................................................................................
57
57
1
1
26
10
1,482
570
Total ..........................................................................................................
57
........................
........................
2,052
VerDate Mar<15>2010
23:01 Jun 23, 2014
Jkt 232001
PO 00000
Frm 00041
Fmt 4703
Sfmt 4703
E:\FR\FM\24JNN1.SGM
24JNN1
]]>Agencies
[Federal Register Volume 79, Number 121 (Tuesday, June 24, 2014)]
[Notices]
[Pages 35759-35761]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 2014-14713]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Substance Abuse and Mental Health Services Administration
Agency Information Collection Activities: Submission for OMB
Review; Comment Request
Periodically, the Substance Abuse and Mental Health Services
Administration (SAMHSA) will publish a summary of information
collection requests under OMB review, in compliance with the Paperwork
Reduction Act (44 U.S.C. Chapter 35). To request a copy of these
[[Page 35760]]
documents, call the SAMHSA Reports Clearance Officer on (240) 276-1243.
Project: 2015 National Survey on Drug Use and Health (OMB No. 0930-
0110)--Revision
The National Survey on Drug Use and Health (NSDUH) is a survey of
the U.S. civilian, non-institutionalized population aged 12 years old
or older. The data are used to determine the prevalence of use of
tobacco products, alcohol, illicit substances, and illicit use of
prescription drugs. The results are used by SAMHSA, the Office of
National Drug Control Policy (ONDCP), Federal government agencies, and
other organizations and researchers to establish policy, direct program
activities, and better allocate resources.
In order to continue producing current data, SAMHSA's Center for
Behavioral Health Statistics and Quality (CBHSQ) must periodically
update aspects of the NSDUH to reflect the changing substance use and
mental health issues and to continue producing current data. CBHSQ has
such plans for the 2015 NSDUH survey year to achieve two goals: (1)
Revise the questionnaire to address changing policy and research data
needs, and (2) modify the survey methodology to improve the quality of
estimates and the efficiency of data collection and processing.
Planned revisions for the 2015 NSDUH to the questionnaire,
methodology and materials, including an assessment of new computer
equipment, were initially tested in 2012 as part of the NSDUH
Questionnaire Field Test (QFT) (OMB No. 0930-0334), then further
refined and tested again in 2013 during the NSDUH Dress Rehearsal (DR)
(OMB No. 0930-0334). As such, most of the changes described herein were
successfully tested as part of the QFT and/or DR unless otherwise
specified.
The changes to the questionnaire content for 2015 will include: (a)
Revisions to modules for smokeless tobacco, hallucinogens, inhalants,
prescription drugs, special drugs, consumption of alcohol, and health
care; (b) revisions to the educational attainment response categories;
(c) a lower threshold of binge alcohol use for females; (d) a new
methamphetamine module; (e) addition of two sexual orientation
questions to be asked of adults; and (f) revisions to back-end
demographics questions. Also, to aid respondent recall within the
questionnaire, prescription drug images and a reference date calendar
will display on the computer screen rather than being displayed in
hard-copy, paper form.
There are a few additional changes to the questionnaire content for
2015 not tested during the DR, which include: (a) The term ``Molly''
will be added to questions about Ecstasy in the hallucinogens module;
(b) routine updates to logic and wording for consistency and to
maximize respondent comprehension; and (c) other minor changes to
questions throughout the instrument to clarify intent.
Several changes are also planned to the methodology for 2015 in an
effort to improve the efficiency of data collection and processing;
these were tested during the QFT and DR. A new 7-inch touch screen
tablet will be used for screening and interview respondent selection,
in addition to a new lightweight laptop used to administer the
questionnaire. Also redesigned versions of the lead letter (mailed to
respondents prior to being contacted by an interviewer) and a question
& answer brochure will be provided to respondents. As necessary, all
materials provided to respondents for 2015 will be updated to now
reference the U.S. Department of Health and Human Services (instead of
U.S. Public Health Service) and any previous mention of the Contractor,
Research Triangle Institute, will now appear as RTI International. Due
to changes to the questionnaire content, the showcard booklet, which
allows respondents to refer to information necessary for accurate
responses, will contain fewer showcards.
Along with the new laptop, text to speech (TTS) software is being
programmed and tested for implementation within the questionnaire for
2015. TTS uses a computer-generated voice to read text displayed on-
screen, rather than relying on the pre-recorded audio files from a
human voice used previously with the audio computer-assisted self-
interviewing (ACASI) portions of the interview. Though TTS was not
tested as part of the QFT or DR, during an evaluation of the software,
there were no problems understanding any words or phrases produced by
the TTS voices in English or Spanish, so it will be implemented for the
2015 NSDUH unless there is a significant problem shown during testing.
If TTS is not implemented, the current method of using pre-recorded
audio files will be continued for the 2015 NSDUH.
In addition, interviewers will now have the option of showing a
short video via the multimedia capability of the touch screen tablet.
The video (approx. 50 seconds in run time) will provide a brief
explanation of the study and why participation is important. Also
contained within the tablet and new for 2015 is a parental introductory
script, designed to be read to a parent or guardian once a youth
respondent is selected to complete an interview. This script will
standardize the introductory conversations with parent/guardians.
As with all NSDUH/NHSDA (prior to 2002, the NSDUH was referred to
as the National Household Survey on Drug Abuse (NHSDA)) surveys
conducted since 1999, the sample size of the survey for 2015 will be
sufficient to permit prevalence estimates for each of the fifty States
and the District of Columbia. The sample design for 2015 will be the
same as the design used for 2014 data collection. This design places
more sample in the 26 or older age groups to more accurately estimate
drug use and related mental health measures among the aging drug use
population, and allows for the possible adoption of address-based
sampling in the future. The total annual burden estimate is shown in
Table 1.
Table 1--Annualized Estimated Burden for 2015 NSDUH
----------------------------------------------------------------------------------------------------------------
Number of Responses per Total number Hours per Total burden
Instrument respondents respondent of responses response hours
----------------------------------------------------------------------------------------------------------------
Household Screening............. 125,176 1 125,176 0.083 10,390
Interview....................... 67,507 1 67,507 1.000 67,507
Screening Verification.......... 3,755 1 3,755 0.067 252
Interview Verification.......... 10,126 1 10,126 0.067 678
-------------------------------------------------------------------------------
Total....................... 125,176 .............. 125,176 .............. 78,827
----------------------------------------------------------------------------------------------------------------
[[Page 35761]]
Written comments and recommendations concerning the proposed
information collection should be sent by July 24, 2014 to the SAMHSA
Desk Officer at the Office of Information and Regulatory Affairs,
Office of Management and Budget (OMB). To ensure timely receipt of
comments, and to avoid potential delays in OMB's receipt and processing
of mail sent through the U.S. Postal Service, commenters are encouraged
to submit their comments to OMB via email to: OIRA_Submission@omb.eop.gov. Although commenters are encouraged to send
their comments via email, commenters may also fax their comments to:
202-395-7285. Commenters may also mail them to: Office of Management
and Budget, Office of Information and Regulatory Affairs, New Executive
Office Building, Room 10102, Washington, DC 20503.
Summer King,
Statistician.
[FR Doc. 2014-14713 Filed 6-23-14; 8:45 am]
BILLING CODE 4162-20-P
